{
  "id": 5427,
  "text": "Clin Oncol 1989;7:1462-1468.Available at: http://www.ncbi.nlm.nih.gov/pubmed/2674333.246.Weiss GR, Green S, Hannigan EV, et al.A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Clin Oncol 1989;7:1462-1468.Available at: http://www.ncbi.nlm.nih.gov/pubmed/2674333.246.Weiss GR, Green S, Hannigan EV, et al.A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "卡铂是一种二代铂类化合物，主要通过与DNA形成交联，从而抑制癌细胞的增殖和分裂。在治疗复发性或转移性宫颈鳞状细胞癌中，根据相关研究证据，卡铂可作为单药化疗方案，表现出一定疗效。研究显示，卡铂的毒性较顺铂低，对肾功能损害较少，耐受性较好，特别对于已经接受过顺铂治疗或无法耐受顺铂的患者，卡铂是一种值得考虑的替代药物。\n\n然而，总体来说，卡铂的单药治疗效果通常较为有限，一些研究报道其有效率在20%上下。因此，目前多建议将卡铂与其他化疗药物或靶向药物联合使用，以提高治疗效果。具体方案及药物组合需根据患者的病情、耐受性以及先前治疗的历史来个体化制定。",
  "query": "**针对复发性或转移性宫颈鳞状细胞癌，卡铂在治疗中的作用和效果如何？**",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: **针对复发性或转移性宫颈鳞状细胞癌，卡铂在治疗中的作用和效果如何？**\n\n<reference text>: Clin Oncol 1989;7:1462-1468.Available at: http://www.ncbi.nlm.nih.gov/pubmed/2674333.246.Weiss GR, Green S, Hannigan EV, et al.A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "卡铂是一种二代铂类化合物，主要通过与DNA形成交联，从而抑制癌细胞的增殖和分裂。在治疗复发性或转移性宫颈鳞状细胞癌中，根据相关研究证据，卡铂可作为单药化疗方案，表现出一定疗效。研究显示，卡铂的毒性较顺铂低，对肾功能损害较少，耐受性较好，特别对于已经接受过顺铂治疗或无法耐受顺铂的患者，卡铂是一种值得考虑的替代药物。\n\n然而，总体来说，卡铂的单药治疗效果通常较为有限，一些研究报道其有效率在20%上下。因此，目前多建议将卡铂与其他化疗药物或靶向药物联合使用，以提高治疗效果。具体方案及药物组合需根据患者的病情、耐受性以及先前治疗的历史来个体化制定。"
}